Allele Biotechnology and Pharmaceuticals, Inc.
Allele Biotechnology and Pharmaceuticals, Inc. (ALLELE) is a San Diego-based company that explores the mechanisms of biological processes to develop technologies and products for biomedical research and therapy development. ALLELE’s mission is to increase accessibility to superior research and clinical assets by offering cutting edge technologies in individual products and fully integrated platforms. Allele utilizes proprietary non-integrating, mRNA-based, cellular reprogramming methods to develop cell therapy using cGMP-grade human iPS cells and their derivatives. In 2018 the company commissioned world’s first commercial cGMP facility that has been custom built for clinical manufacturing of pluripotent stem cells and their derived products.
